Weight gain in smokers after quitting cigarettes: meta-analysis

被引:358
作者
Aubin, Henri-Jean [1 ,2 ]
Farley, Amanda [3 ]
Lycett, Deborah [3 ]
Lahmek, Pierre [2 ]
Aveyard, Paul [3 ]
机构
[1] Univ Paris Sud, Hop Paul Brousse, AP HP,U669, Ctr Enseignement Rech & Traitement Addict,INSERM, F-94804 Villejuif, France
[2] Hop Emile Roux, Ctr Traitement Addict, Limeil Brevannes, France
[3] Univ Birmingham, UK Ctr Tobacco Control Studies, Birmingham, W Midlands, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2012年 / 345卷
基金
英国经济与社会研究理事会; 英国医学研究理事会;
关键词
RECEPTOR PARTIAL AGONIST; TRANSDERMAL NICOTINE PATCH; SUSTAINED-RELEASE BUPROPION; DOUBLE-BLIND TRIAL; BODY-MASS INDEX; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; SMOKING-CESSATION; FOLLOW-UP;
D O I
10.1136/bmj.e4439
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To describe weight gain and its variation in smokers who achieve prolonged abstinence for up to 12 months and who quit without treatment or use drugs to assist cessation. Design Meta-analysis. Data sources We searched the Central Register of Controlled Trials (CENTRAL) and trials listed in Cochrane reviews of smoking cessation interventions (nicotine replacement therapy, nicotinic partial agonists, antidepressants, and exercise) for randomised trials of first line treatments (nicotine replacement therapy, bupropion, and varenicline) and exercise that reported weight change. We also searched CENTRAL for trials of interventions for weight gain after cessation. Review methods Trials were included if they recorded weight change from baseline to follow-up in abstinent smokers. We used a random effects inverse variance model to calculate the mean and 95% confidence intervals and the mean of the standard deviation for weight change from baseline to one, two, three, six, and 12 months after quitting. We explored subgroup differences using random effects meta-regression. Results 62 studies were included. In untreated quitters, mean weight gain was 1.12 kg (95% confidence interval 0.76 to 1.47), 2.26 kg (1.98 to 2.54), 2.85 kg (2.42 to 3.28), 4.23 kg (3.69 to 4.77), and 4.67 kg (3.96 to 5.38) at one, two, three, six, and 12 months after quitting, respectively. Using the means and weighted standard deviations, we calculated that at 12 months after cessation, 16%, 37%, 34%, and 13% of untreated quitters lost weight, and gained less than 5 kg, gained 5-10 kg, and gained more than 10 kg, respectively. Estimates of weight gain were similar for people using different pharmacotherapies to support cessation. Estimates were also similar between people especially concerned about weight gain and those not concerned. Conclusion Smoking cessation is associated with a mean increase of 4-5 kg in body weight after 12 months of abstinence, and most weight gain occurs within three months of quitting. Variation in weight change is large, with about 16% of quitters losing weight and 13% gaining more than 10 kg.
引用
收藏
页数:21
相关论文
共 107 条
[61]   The efficacy and safety of varenicline for smoking cessation using strategy in adult a flexible dosing smokers: a randomized controlled trial [J].
Niaura, Raymond ;
Hays, J. Taylor ;
Jorenby, Douglas E. ;
Leone, Frank T. ;
Pappas, John E. ;
Reeves, Karen R. ;
Williams, Kathryn E. ;
Billing, Clare B., Jr. .
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (07) :1931-1941
[62]   Smoking cessation with varenicline, a selective α4β2 nicotinic receptor partial agonist -: Results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up [J].
Nides, Mitchell ;
Oncken, Cheryl ;
Gonzales, David ;
Rennard, Stephen ;
Watsky, Eric J. ;
Anziano, Rich ;
Reeves, Karen R. .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) :1561-1568
[63]   The effect of ephedrine plus caffeine on smoking cessation and postcessation weight gain [J].
Norregaard, J ;
Jorgensen, S ;
Mikkelsen, KL ;
Tonnesen, P ;
Iversen, E ;
Sorensen, T ;
Soeberg, B ;
Jakobsen, HB .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1996, 60 (06) :679-686
[64]  
O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706
[65]   A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation [J].
O'Malley, SS ;
Cooney, JL ;
Krishnan-Sarin, S ;
Dubin, JA ;
McKee, SA ;
Cooney, NL ;
Blakeslee, A ;
Meandzija, B ;
Romano-Dahlgard, D ;
Wu, R ;
Makuch, R ;
Jatlow, P .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (06) :667-674
[66]   Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation [J].
Oncken, Cheryl ;
Gonzales, David ;
Nides, Mitchell ;
Rennard, Stephen ;
Watsky, Eric ;
Billing, Clare B. ;
Anziano, Richard ;
Reeves, Karen .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (15) :1571-1577
[67]  
Pack Quinn R, 2008, WMJ, V107, P237
[68]   A proof of concept randomised placebo controlled factorial trial to examine the efficacy of St John's wort for smoking cessation and chromium to prevent weight gain on smoking cessation [J].
Parsons, Amanda ;
Ingram, Jackie ;
Inglis, Jennie ;
Aveyard, Paul ;
Johnstone, Elaine ;
Brown, Karen ;
Franklin, Mike ;
Bermudez, Isabel .
DRUG AND ALCOHOL DEPENDENCE, 2009, 102 (1-3) :116-122
[69]   Joint effects of tobacco use and body mass on all-cause mortality in Mumbai, India: Results from a population-based cohort study [J].
Pednekar, Mangesh S. ;
Gupta, Prakash C. ;
Hebert, James R. ;
Hakama, Matti .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (03) :330-340
[70]   WEIGHT-GAIN FOLLOWING SMOKING CESSATION [J].
PERKINS, KA .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1993, 61 (05) :768-777